Cancer
Medicine to prevent bone loss may help lower risk of ovarian cancer
A study of tens of thousands of women suggests a common bone density drug could lower the risk of ovarian cancer.
- by Stuart Layt
Latest
Weight loss tied to a dramatic drop in cancer risk
A new study sends the message that people should seek to lose weight in whatever way they can, whether through diet and exercise or with help from medical therapies.
- by Anahad O'Connor
Protein molecule link to melanoma outcomes
South Australian researchers have discovered a particular protein may determine the fate of people with skin cancer.
- by Tim Dornin
‘One-stop’ $750m cancer centre planned at Brisbane hospital
Queensland’s Health Minister says the centre will be world-leading and a first in the country.
- by Cloe Read
‘Hope for all cancers’: Small trial makes 100% of tumours disappear
It’s a small drug trial with “unheard of’” results is having a seismic impact in the world of oncology.
- by Kim Bellware
New research confirms some melanomas may be harmless - but which ones?
The research backs up previous findings that cancer screening programs are saving lives, but are also causing some people to receive invasive treatments they do not need.
- by Stuart Layt
Why it’s important for AFL players to speak up about testicular cancer
Playing AFL, or any other sport where trauma to the testicles may occur, does not increase the chance of developing testicular cancer.
- by Alexander Dabb
Albanese expands access to fourth doses of COVID-19 vaccine for 1.5 million people
Immunocompromised Australians will be eligible for a fourth COVID-19 vaccine dose ahead of winter.
- by Dana Daniel
Cancer patients still waiting on treatment centres promised at last election
The federal government promised $63 million during the 2019 election campaign for radiotherapy centres in 13 locations across regional Australia. But many of the projects have not progressed.
- by Dana Daniel
Breast reconstructions after cancer surged, then the pandemic shut down elective surgeries
However, surgeons are concerned elective surgery shutdowns have blown out wait times, making reconstructions more inaccessible for those without private health.
- by Mary Ward
‘Invest bravely’: Cancer-fighting giant sets sights on Australia
Australia’s streamlined trials approval system and its diverse patient population attracted the Beijing-founded pharmaceuticals firm.
- by Emma Koehn